- 優先名称
- Nuezhenoside G13
- IUPAC
- methyl (4S,5E,6S)-5-ethylidene-4-[2-[[(2R,3S,4S,5R,6R)-6-[2-[4-[2-[(2S,3E,4S)-3-ethylidene-5-methoxycarbonyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4H-pyran-4-yl]acetyl]oxyphenyl]ethoxy]-3,4,5-trihydroxyoxan-2-yl]methoxy]-2-oxoethyl]-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4H-pyran-3-carboxylate
- 現地名
- GL3
- 英語名
- G13
- 分子式
- C48H64O27
- 分子量
- 1073.01
名称と別名
60037-39-0Nuezhenoside G13GL3orb1217831orb1297570SCHEMBL29940775HY-N6873C48H64O27MFCD32263060TN1074AKOS040760138EBC-617285
名称をさらに表示
6-アミノ-9-(6-メトキシナフタレン-2-イル)-3H-チオキサンテン-3-イミニウム9-(6-メトキシ-2-ナフチル)-6-イミニオ-6H-チオキサンテン-3-アミンGI3G13CREBL1GL3, 10 mM in DMSOligustroflavone G13inhibit,GL 3,GL-3,Inhibitor,GL32H-Pyran-4-acetic acid, 3-ethylidene-2-(β-D-glucopyranosyloxy)-3,4-dihydro-5-(methoxycarbonyl)-, 4-[2-[[6-O-[[(2S,3E,4S)-3-ethylidene-2-(β-D-glucopyranosyloxy)-3,4-dihydro-5-(methoxycarbonyl)-2H-pyran-4-yl]acetyl]-β-D-glucopyranosyl]oxy]ethyl]phenyl ester, (2S,3E,4S)-Methyl (2S,4S,E)-3-ethylidene-4-(2-(4-(2-(((2R,3R,4S,5S,6R)-6-((2-((2S,4S,E)-3-ethylidene-5-(methoxycarbonyl)-2-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-3,4-dihydro-2H-pyran-4-yl)acetoxy)methyl)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)ethyl)phenoxy)-2-oxoethyl)-2-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-3,4-dihydro-2H-pyran-5-carboxylate